Otc - Active Ingredient
Active Ingredient
Salicylic Acid 2.0%
The following Structured Product Label (SPL) was submitted to the FDA by The Hain Celestial Group, Inc. for the product Alba Acnedote Invisible Treatment (NDC 61995-2764). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, dosage & administration, otc - purpose, warnings, otc - keep out of reach of children, inactive ingredient, indications & usage, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active Ingredient
Salicylic Acid 2.0%
Cleanse face and apply directly to blemishes morning, evening and more frequently if needed.
Acne Treatment
For external use only. Using other topical acne medications at the same time or immediately following the use of this product may increase dryness and irritation of the skin. If this occurs, only one drug should be used unless directed by a doctor. Avoid direct contact with eyes. If contact occurs, flush throughly with water.
Keep out of reach of children. If swallowed get medical help or contact Poison Center right away.
Water, ,Glycerin, Alcohol, Aloe Barbadensis Leaf Juice(1), Hamamelis Verginiana (Witch Hazel) Water, Hydroxyethylcellulose, Spiraea Ulmaria Extract, Lens Esculenta (Lentil) Fruit Extract, Arnica Montana (Flower) Extract (1), Camellia Sinensis Leaf Extract (1), Chamomilla Recutita (Matricaria) Flower Extract (1), Calendula Officinalis Flower Extract (1), Lavandula Angustifolia (Lavender) Extract (1), Glycyrrhiza Glabra (Licorice) Rhizome/Root, Salix Alba (Willow) Bark Extract (1),Citrus Aurantium Dulcis (Orange) Peel Oil (2), Citrus Aurantium Bergamia (Bergamot) Oil (2), Mentha Piperita (Peppermint) Oil (2)
(1) Certified Organicf Ingredient; (2) Natural Fragrance
For the treatment of acne.
* Please review the disclaimer below.